Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Richard Channick, MD, chair for this educational event, receives research funds from Altavant, Aerovate, Respira, and Merck; and receives consulting fees from Altavant, Aerovate, Respira, and Merck.
Jean Elwing, MD, chair for this educational event, receives research funds from United Therapeutics, Gossamer Bio, Bayer, Acceleron/Merck, Altavant, Aerovate, Pharmosa, Janssen and Lung LLC; and receives consulting fees from United Therapeutics, Gossamer Bio, Bayer, Acceleron/Merck, Altavant, Aerovate, Pharmosa, Janssen and Lung LLC.
Dinesh Khanna, MD, MS, chair for this educational event, receives research funds from Boehringer Ingelheim, BMS, Bayer and Pfizer; and receives consulting fees from Astra Zeneca, Boehringer Ingelheim, BMS, Chemomab, Horizon, Prometheus, Janssen and UCB.
Martha Kingman, FNP-C, DNP, chair for this educational event, receives consulting fees from Janssen, Liquidia, Aerovate, Aerami, Merck and Gossamer.
Richard Krasuski, MD, chair for this educational event, receives research funds from Actelion/Janssen, Artivion, Adult Congenital Heart Association, Corvia, Edwards Lifesciences and Medtronic; and receives consulting fees from Actelion/Janssen, Bayer, W.L Gore, Medtronic and Neptune Medical.
Vallerie V. McLaughlin, MD, chair for this educational event, receives research funds from Aerovate, Altavant, Gossamer-Bio, Janssen, Merck and Sonovie; and receives consulting fees from Aerami, Aerovate, Altavant, Bayer, Caremark, L.L.C., Corvista, Gossamer Bio, Janssen, Merck and United Therapeutics.
Sudarshan Rajagopal, MD, PhD, chair for this educational event, receives research funds from Janssen, United Therapeutics and Altavant; receives royalties and is a patent holder for Polarean; receives consulting fees from Aerami, Altavant, GossamerBio, Insmed, Janssen, Liquidia, Polarean, United Therapeutics and Visterra; and has ownership interest in Apie Therapeutics.
Rajan Saggar MD, chair for this educational event, receives consulting fees from Janssen, Aerovate, United Therapeutics, Third Pole and Aria.
Oksana A. Shlobin, MD, chair for this educational event, receives consulting fees from UT, Janssen, Bayer, Altavant, Aerami, Aerovate and Merck.
Facebook Comments